Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Business Insider1d
Novo Nordisk Executives Purchase ADRs on NYSE
Novo Nordisk (NVO) has released an update. Novo Nordisk has disclosed recent transactions involving the purchase of 1,300 American Depositary Receipts (ADRs) by its board members and executives. This ...
EU Regulators Quiz Novo Nordisk, Catalent Rivals on $16.5 Billion Deal
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Ad Age4d
Novo Nordisk reframes weight loss, centering support over solitude
Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...
Novo Nordisk placed on ‘Positive Catalyst Watch’ at JPMorgan
JPMorgan placed shares of Novo Nordisk (NVO) on “Positive Catalyst Watch” ahead of the CagriSema REDEFINE 1 obesity data. The ...
Newser on MSN6d
Can't Get Ozempic? There's Concern Over Copycats
Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...